KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Equity Average (2016 - 2025)

Historic Equity Average for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $7.3 billion.

  • Quest Diagnostics' Equity Average rose 787.58% to $7.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 billion, marking a year-over-year increase of 787.58%. This contributed to the annual value of $6.6 billion for FY2024, which is 719.52% up from last year.
  • Per Quest Diagnostics' latest filing, its Equity Average stood at $7.3 billion for Q3 2025, which was up 787.58% from $7.1 billion recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Equity Average registered a high of $7.3 billion during Q3 2025, and its lowest value of $6.0 billion during Q1 2023.
  • For the 5-year period, Quest Diagnostics' Equity Average averaged around $6.5 billion, with its median value being $6.4 billion (2022).
  • Per our database at Business Quant, Quest Diagnostics' Equity Average surged by 1939.42% in 2021 and then crashed by 682.28% in 2023.
  • Over the past 5 years, Quest Diagnostics' Equity Average (Quarter) stood at $6.5 billion in 2021, then dropped by 5.52% to $6.1 billion in 2022, then grew by 4.94% to $6.4 billion in 2023, then grew by 6.63% to $6.8 billion in 2024, then rose by 6.64% to $7.3 billion in 2025.
  • Its Equity Average was $7.3 billion in Q3 2025, compared to $7.1 billion in Q2 2025 and $6.9 billion in Q1 2025.